Dipyridamole Injection
Product Images NDC 51662-1447

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dipyridamole (NDC 51662-1447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse (Adverse)

This text provides a table that shows the incidence percentage of drug-related adverse events, which includes different symptoms such as chest pain, headache, dizziness, nausea, and more.*

FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

This is a description of a medication called Dipyridamole, provided in the form of an injection. It is distributed by HF Acquisition Co., LLC in the United States, and its National Drug Code is 0641-2569-41. The injection is meant for intravenous use only, specifically to aid in myocardial imaging. The injection contains 50mg of Dipyridamole per 10 mL, and the manufacturer's package insert should be consulted for more information.*

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Label (Vial Label)

This is a description of a medication available as a 50 mg/10 mL single dose vial. The name of the medication is not provided, but it appears to be intended for intravenous use in the treatment of cardiovascular conditions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.